Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
6,522,482
-
Shares change
-
+1,609,626
-
Total reported value, excl. options
-
$47,890,908
-
Value change
-
+$11,616,365
-
Put/Call ratio
-
77.75%
-
Number of buys
-
47
-
Number of sells
-
-21
-
Price
-
$7.34
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q1 2020
85 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q1 2020.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,522,482 shares
of 27,407,170 outstanding shares and own 23.8% of the company stock.
Largest 10 shareholders include Parkman Healthcare Partners LLC (725,590 shares), RENAISSANCE TECHNOLOGIES LLC (659,570 shares), G2 Investment Partners Management LLC (614,164 shares), EAM Investors, LLC (510,665 shares), BlackRock Inc. (408,527 shares), Fairpointe Capital LLC (349,627 shares), EAM Global Investors LLC (245,619 shares), Manatuck Hill Partners, LLC (210,400 shares), MILLENNIUM MANAGEMENT LLC (205,965 shares), and WELLINGTON MANAGEMENT GROUP LLP (203,595 shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.